会員登録
ログイン
【4598】Delta-Fly Pharma
創薬。抗がん剤。
類似企業：
【業界1位】
武田薬品工業
【業界1位】
武田薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027.03 | 2026/08/07 | Q1予 | - | - | - | - | -1,330 | → | 0.0% | 0.0% | -1,340 | → | 0.0% | 0.0% | -1,350 | → | 0.0% | 0.0% |
| 2027.03 | 2026/05/15 | 当初予 | - | - | - | - | -1,330 | - | - | - | -1,340 | - | - | - | -1,350 | - | - | - |
| 2026.03 | 2026/05/15 | 実 | 0 | - | - | - | -1,605 | ↓ | -7.0% | -7.0% | -1,623 | ↓ | -7.5% | -7.5% | -1,625 | ↓ | -7.5% | -7.5% |
| 2026.03 | 2026/02/13 | Q3予 | - | - | - | - | -1,500 | → | 0.0% | 0.0% | -1,510 | → | 0.0% | 0.0% | -1,512 | → | 0.0% | 0.0% |
| 2026.03 | 2025/11/14 | Q2予 | - | - | - | - | -1,500 | → | 0.0% | 0.0% | -1,510 | → | 0.0% | 0.0% | -1,512 | → | 0.0% | 0.0% |
| 2026.03 | 2025/08/08 | Q1予 | - | - | - | - | -1,500 | → | 0.0% | 0.0% | -1,510 | → | 0.0% | 0.0% | -1,512 | → | 0.0% | 0.0% |
| 2026.03 | 2025/05/15 | 当初予 | - | - | - | - | -1,500 | - | - | - | -1,510 | - | - | - | -1,512 | - | - | - |
| 2025.03 | 2025/05/15 | 実 | 0 | - | - | - | -1,708 | ↑ | +6.0% | +6.0% | -1,718 | ↑ | +6.0% | +6.0% | -1,721 | ↑ | +5.9% | +5.9% |
| 2025.03 | 2025/02/14 | Q3予 | - | - | - | - | -1,817 | → | 0.0% | 0.0% | -1,827 | → | 0.0% | 0.0% | -1,829 | → | 0.0% | 0.0% |
| 2025.03 | 2024/11/14 | Q2予 | - | - | - | - | -1,817 | → | 0.0% | 0.0% | -1,827 | → | 0.0% | 0.0% | -1,829 | → | 0.0% | 0.0% |
| 2025.03 | 2024/08/09 | Q1予 | - | - | - | - | -1,817 | → | 0.0% | 0.0% | -1,827 | → | 0.0% | 0.0% | -1,829 | → | 0.0% | 0.0% |
| 2025.03 | 2024/05/15 | 当初予 | - | - | - | - | -1,817 | - | - | - | -1,827 | - | - | - | -1,829 | - | - | - |
| 2024.03 | 2024/05/15 | 実 | 0 | - | - | - | -1,403 | ↓ | -6.9% | -6.9% | -1,426 | ↓ | -8.0% | -8.0% | -1,429 | ↓ | -8.0% | -8.0% |
| 2024.03 | 2024/02/13 | Q3予 | - | - | - | - | -1,312 | → | 0.0% | 0.0% | -1,320 | → | 0.0% | 0.0% | -1,323 | → | 0.0% | 0.0% |
| 2024.03 | 2023/11/13 | Q2予 | - | - | - | - | -1,312 | → | 0.0% | 0.0% | -1,320 | → | 0.0% | 0.0% | -1,323 | → | 0.0% | 0.0% |
| 2024.03 | 2023/08/14 | Q1予 | - | - | - | - | -1,312 | → | 0.0% | 0.0% | -1,320 | → | 0.0% | 0.0% | -1,323 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/15 | 当初予 | - | - | - | - | -1,312 | - | - | - | -1,320 | - | - | - | -1,323 | - | - | - |
| 2023.03 | 2023/05/15 | 実 | 0 | ↓ | -100.0% | -100.0% | -1,315 | → | 0.0% | -14.3% | -1,325 | → | 0.0% | -15.2% | -1,328 | → | 0.0% | -15.5% |
| 2023.03 | 2023/04/21 | 修正予 | - | - | - | - | -1,315 | ↓ | -14.3% | -14.3% | -1,325 | ↓ | -15.2% | -15.2% | -1,328 | ↓ | -15.5% | -15.5% |
| 2023.03 | 2023/02/14 | Q3予 | 300 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% |
| 2023.03 | 2022/11/14 | Q2予 | 300 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% |
| 2023.03 | 2022/08/12 | Q1予 | 300 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% | -1,150 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/13 | 当初予 | 300 | - | - | - | -1,150 | - | - | - | -1,150 | - | - | - | -1,150 | - | - | - |
| 2022.03 | 2022/05/13 | 実 | 300 | → | 0.0% | +200.0% | -961 | ↑ | +12.6% | +26.1% | -964 | ↑ | +12.4% | +25.8% | -967 | ↑ | +12.1% | +25.6% |
| 2022.03 | 2022/03/08 | 修正予 | 300 | ↑ | +200.0% | +200.0% | -1,100 | ↑ | +15.4% | +15.4% | -1,100 | ↑ | +15.4% | +15.4% | -1,100 | ↑ | +15.4% | +15.4% |
| 2022.03 | 2022/02/14 | Q3予 | 100 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% |
| 2022.03 | 2021/11/11 | Q2予 | 100 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% |
| 2022.03 | 2021/08/13 | Q1予 | 100 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/14 | 当初予 | 100 | - | - | - | -1,300 | - | - | - | -1,300 | - | - | - | -1,300 | - | - | - |
| 2021.03 | 2021/05/14 | 実 | 300 | → | 0.0% | 0.0% | -852 | ↓ | -0.2% | -0.2% | -859 | ↓ | -1.1% | -1.1% | -862 | ↓ | -1.4% | -1.4% |
| 2021.03 | 2021/02/12 | Q3予 | 300 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% |
| 2021.03 | 2020/11/12 | Q2予 | 300 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% |
| 2021.03 | 2020/08/14 | Q1予 | 300 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% |
| 2021.03 | 2020/05/14 | 当初予 | 300 | - | - | - | -850 | - | - | - | -850 | - | - | - | -850 | - | - | - |
| 2020.03 | 2020/05/14 | 実 | 100 | → | 0.0% | 0.0% | -1,545 | ↓ | -1.6% | -44.9% | -1,552 | ↓ | -1.6% | -45.6% | -1,555 | ↓ | -1.6% | -45.5% |
| 2020.03 | 2020/03/24 | 修正予 | 100 | - | - | - | -1,520 | ↓ | -42.6% | -42.6% | -1,527 | ↓ | -43.2% | -43.2% | -1,531 | ↓ | -43.2% | -43.2% |
| 2020.03 | 2020/02/14 | Q3予 | - | - | - | - | -1,066 | → | 0.0% | 0.0% | -1,066 | → | 0.0% | 0.0% | -1,069 | → | 0.0% | 0.0% |
| 2020.03 | 2019/11/14 | Q2予 | - | - | - | - | -1,066 | → | 0.0% | 0.0% | -1,066 | → | 0.0% | 0.0% | -1,069 | → | 0.0% | 0.0% |
| 2020.03 | 2019/08/14 | Q1予 | - | - | - | - | -1,066 | → | 0.0% | 0.0% | -1,066 | → | 0.0% | 0.0% | -1,069 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/15 | 当初予 | - | - | - | - | -1,066 | - | - | - | -1,066 | - | - | - | -1,069 | - | - | - |
| 2019.03 | 2019/05/15 | 実 | 0 | → | - | -100.0% | -592 | ↑ | +13.2% | +13.2% | -671 | ↓ | -2.6% | +9.2% | -673 | ↓ | -2.4% | +9.2% |
| 2019.03 | 2019/03/26 | 修正予 | 0 | ↓ | -100.0% | -100.0% | - | - | - | - | -654 | ↑ | +11.5% | +11.5% | -657 | ↑ | +11.3% | +11.3% |
| 2019.03 | 2019/02/14 | Q3予 | 200 | → | 0.0% | 0.0% | -682 | → | 0.0% | 0.0% | -739 | → | 0.0% | 0.0% | -741 | → | 0.0% | 0.0% |
| 2019.03 | 2018/11/14 | 当初予 | 200 | - | - | - | -682 | - | - | - | -739 | - | - | - | -741 | - | - | - |
